Clinical trial
PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction
NCT02819440 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- June 30, 2020
- Enrollment
- 141 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, obese